Chesney, E.; Mazibuko, N.; Oliver, D.; Minichino, A.; Lamper, A.D.; Chester, L.; Reilly, T.J.; Lloyd, M.; Kråkström, M.; Dickens, A.M.;
et al. Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD). Pharmaceutics 2024, 16, 1537.
https://doi.org/10.3390/pharmaceutics16121537
AMA Style
Chesney E, Mazibuko N, Oliver D, Minichino A, Lamper AD, Chester L, Reilly TJ, Lloyd M, Kråkström M, Dickens AM,
et al. Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD). Pharmaceutics. 2024; 16(12):1537.
https://doi.org/10.3390/pharmaceutics16121537
Chicago/Turabian Style
Chesney, Edward, Ndabezinhle Mazibuko, Dominic Oliver, Amedeo Minichino, Ayşe Doğa Lamper, Lucy Chester, Thomas J. Reilly, Millie Lloyd, Matilda Kråkström, Alex M. Dickens,
and et al. 2024. "Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)" Pharmaceutics 16, no. 12: 1537.
https://doi.org/10.3390/pharmaceutics16121537
APA Style
Chesney, E., Mazibuko, N., Oliver, D., Minichino, A., Lamper, A. D., Chester, L., Reilly, T. J., Lloyd, M., Kråkström, M., Dickens, A. M., Orešič, M., Lynch, E., Stoloff, G., Mehta, M. A., & McGuire, P.
(2024). Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD). Pharmaceutics, 16(12), 1537.
https://doi.org/10.3390/pharmaceutics16121537
